CIBC World Market’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,215
| Closed | -$211K | – | 1404 |
|
|
2024
Q4 | $211K | Buy |
+3,215
| New | +$221K | ﹤0.01% | 1283 |
|
|
2019
Q2 | – | Sell |
-4,701
| Closed | -$241K | – | 1179 |
|
|
2019
Q1 | $241K | Buy |
+4,701
| New | +$234K | ﹤0.01% | 1034 |
|
|
2018
Q4 | – | Sell |
-73,452
| Closed | -$4.11M | – | 1144 |
|
|
2018
Q3 | $4.11M | Buy |
+73,452
| New | +$4.01M | 0.02% | 340 |
|
|
2018
Q2 | – | Sell |
-4,650
| Closed | -$229K | – | 1200 |
|
|
2018
Q1 | $229K | Hold |
4,650
| – | – | ﹤0.01% | 1062 |
|
|
2017
Q4 | $239K | Hold |
4,650
| – | – | ﹤0.01% | 716 |
|
|
2017
Q3 | $242K | Hold |
4,650
| – | – | ﹤0.01% | 681 |
|
|
2017
Q2 | $240K | Hold |
4,650
| – | – | ﹤0.01% | 1029 |
|
|
2017
Q1 | $234K | Sell |
4,650
-7,143
| -61% | -$354K | ﹤0.01% | 905 |
|
|
2016
Q4 | $556K | Buy |
11,793
+4,413
| +60% | +$209K | ﹤0.01% | 758 |
|
|
2016
Q3 | $368K | Buy |
7,380
+144
| +2% | +$7.3K | ﹤0.01% | 805 |
|
|
2016
Q2 | $348K | Sell |
7,236
-1,257
| -15% | -$59.8K | ﹤0.01% | 740 |
|
|
2016
Q1 | $388K | Sell |
8,493
-4,908
| -37% | -$230K | ﹤0.01% | 666 |
|
|
2015
Q4 | $722K | Sell |
13,401
-14,607
| -52% | -$768K | ﹤0.01% | 551 |
|
|
2015
Q3 | $1.38M | Sell |
28,008
-18,978
| -40% | -$1.09M | 0.01% | 377 |
|
|
2015
Q2 | $2.74M | Buy |
46,986
+16,620
| +55% | +$971K | 0.01% | 277 |
|
|
2015
Q1 | $1.75M | Buy |
30,366
+10,482
| +53% | +$573K | 0.01% | 325 |
|
|
2014
Q4 | $1M | Sell |
19,884
-11,757
| -37% | -$573K | ﹤0.01% | 448 |
|
|
2014
Q3 | $1.48M | Buy |
31,641
+24,108
| +320% | +$1.09M | 0.01% | 335 |
|
|
2014
Q2 | $339K | Buy |
7,533
+2,022
| +37% | +$87K | ﹤0.01% | 594 |
|
|
2014
Q1 | $233K | Buy |
+5,511
| New | +$231K | ﹤0.01% | 653 |
|
Other funds holding IHE
